Gujarat Kidney And Super Speciality Limited (NSE:GKSL)
India · Delayed Price · Currency is INR 127.21
+0.17 (0.13%)
At close: Jul 31, 2026
NSE:GKSL Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Assets
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Equivalents | 132.82 | 25.96 | 9.7 | 0.04 | 0.03 |
Cash & Short-Term Investments | 132.82 | 25.96 | 9.7 | 0.04 | 0.03 |
Cash Growth | 411.65% | 167.52% | 27247.54% | 5.13% | 221.47% |
Accounts Receivable | 386.29 | 151.55 | 42.02 | 11.5 | 11.61 |
Other Receivables | 15.76 | - | - | - | - |
Receivables | 410.55 | 151.55 | 42.02 | 11.5 | 11.61 |
Inventory | 20.55 | 6.75 | 2.7 | - | - |
Prepaid Expenses | - | 0.65 | 2.96 | - | - |
Other Current Assets | 481.96 | 33.46 | 9.9 | - | 0.5 |
Total Current Assets | 1,046 | 218.38 | 67.29 | 11.53 | 12.14 |
Property, Plant & Equipment | 377.78 | 238.81 | 136.41 | 26.72 | 26.72 |
Long-Term Investments | 29.36 | 15.91 | - | - | - |
Goodwill | 907.32 | 71.31 | - | - | - |
Long-Term Deferred Tax Assets | 25.2 | 6.77 | 0.26 | 0.4 | 0.4 |
Long-Term Deferred Charges | - | - | - | 0.06 | 0.06 |
Other Long-Term Assets | 590.86 | 2.27 | 1.3 | - | - |
Total Assets | 2,976 | 553.45 | 205.26 | 38.72 | 39.32 |
Liabilities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Accounts Payable | 84.56 | 32.47 | 21.94 | 34.68 | 34.67 |
Accrued Expenses | 42.8 | 13.04 | 7.9 | 0.29 | 0.29 |
Short-Term Debt | - | 12.88 | - | - | - |
Current Portion of Long-Term Debt | 139.3 | 4.48 | 4.14 | - | - |
Current Portion of Leases | 9.65 | 5.45 | 2.24 | - | - |
Current Income Taxes Payable | - | 15.44 | 3.64 | - | 0.55 |
Other Current Liabilities | 1.84 | 133.16 | 2.52 | - | 0 |
Total Current Liabilities | 278.15 | 216.92 | 42.39 | 34.97 | 35.51 |
Long-Term Debt | 17.86 | 21.44 | 15.3 | - | - |
Long-Term Leases | 124.28 | 38.84 | 36.97 | - | - |
Pension & Post-Retirement Benefits | 7.65 | 4.48 | 2.55 | - | - |
Other Long-Term Liabilities | 1.1 | 0.5 | - | - | - |
Total Liabilities | 429.05 | 282.18 | 97.21 | 34.97 | 35.51 |
Shareholders' Equity
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Common Stock | 157.69 | 113.69 | 2 | 2 | 2 |
Additional Paid-In Capital | - | 48.36 | - | - | - |
Retained Earnings | - | 94.13 | 15.41 | 1.75 | 1.81 |
Comprehensive Income & Other | 2,367 | 3.19 | 90.64 | - | - |
Total Common Equity | 2,525 | 259.36 | 108.04 | 3.75 | 3.81 |
Minority Interest | 22.23 | 11.9 | - | - | - |
Shareholders' Equity | 2,547 | 271.26 | 108.04 | 3.75 | 3.81 |
Total Liabilities & Equity | 2,976 | 553.45 | 205.26 | 38.72 | 39.32 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Total Debt | 291.09 | 83.09 | 58.65 | - | - |
Net Cash (Debt) | -158.27 | -57.13 | -48.95 | 0.04 | 0.03 |
Net Cash Growth | - | - | - | 5.13% | 221.47% |
Net Cash Per Share | -2.54 | -1.12 | -1.40 | 0.00 | 0.00 |
Filing Date Shares Outstanding | 62.25 | 56.84 | 35 | 35 | 35 |
Total Common Shares Outstanding | 62.25 | 56.84 | 35 | 35 | 35 |
Working Capital | 767.73 | 1.47 | 24.9 | -23.43 | -23.37 |
Book Value Per Share | 40.57 | 4.56 | 3.09 | 0.11 | 0.11 |
Tangible Book Value | 1,618 | 188.05 | 108.04 | 3.75 | 3.81 |
Tangible Book Value Per Share | 25.99 | 3.31 | 3.09 | 0.11 | 0.11 |
Land | - | 15.84 | - | - | - |
Buildings | - | 84.4 | 12.23 | - | - |
Machinery | - | 143.69 | 87.98 | 39.2 | 39.2 |